Glucocorticoids and the risk of osteoporosis

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.1, 2009-01, pp. : 33-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased CV risk with glucocorticoids in Cushing's

Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis

By Cranney Ann

Drug Safety, Vol. 28, Iss. 8, 2005-01 ,pp. : 721-730

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis

By Devogelaer J-P.

Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. : 141-154

Adis International

Access to resources Recommend Favorite

Minimising the risk of heparin-induced osteoporosis during pregnancy

By Hawkins David Evans Jeffrey

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 583-590

Informa Healthcare

Access to resources Recommend Favorite

Risk of osteoporosis and fracture incidence in patients on antipsychotic medication

By Graham Simon Matthew Howgate Daniel Anderson William Howes Claire Heliotis Manolis Mantalaris Athanassios Tsiridis Eleftherios Tsapakis Evangelia

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 575-602

Informa Healthcare

Access to resources Recommend Favorite